Stem cell contact lenses for dry eye in Sjögren's
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This trial tests a special contact lens made from stem cells to treat dry eye caused by Sjögren's syndrome. It may help if standard treatments like artificial tears or steroid drops haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with Sjögren's syndrome and it affects your eyes.
- Your eye symptoms have not improved after at least 3 months of standard care, like artificial tears or steroid drops.
- You are not allergic to any part of the study lens.
- You do not have an active eye infection, other serious eye disease, or had eye surgery in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an exosome treatment for people with Sjögren's syndrome whose dry eye symptoms haven't improved with standard care like artificial tears or steroid drops. The goal is to see if this new approach can help relieve eye discomfort.
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
This trial tests a lens made from stem cells to treat dry, painful eyes caused by chronic graft-versus-host disease (cGVHD) after a stem cell transplant. It may help people whose current treatments aren't working well.
This trial tests if using special eye drops (cyclosporine) along with tiny plugs placed in the tear ducts can improve dry eye symptoms in people with Sjögren's syndrome. The goal is to see if this combination works better than the drops alone.
This early-stage trial tests whether special cells derived from umbilical cord tissue can help treat dry eye disease. The treatment uses tiny particles called extracellular vesicles that may reduce eye dryness and improve comfort.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
Hear when a new Sjögren's Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.